Interleukin-6 (IL-6) is a proinflammatory cytokine which is produced by both lymphoid and nonlymphoid cells.
IL-6 is a multifunctional cytokine acting in various cells. It induces the differentiation of B cells to antibody-producing plasma cells, T-cell growth and differentiation, the differentiation of myeloid leukemic cell lines into macrophages, megakaryocyte maturation, the neuronal differentiation of PC12 cells, development of osteoclasts, and acute-phase protein synthesis in hepatocytes. [8] [9] [10] [11] [12] [13] [14] IL-6 acts as a growth factor for myeloma/plasmacytoma, keratinocytes, mesangial cells, renal carcinoma, and Kaposi's sarcoma, but inhibits the growth of myeloid leukemia cell lines and certain sarcoma cell lines. 15, 16) Thereby, IL-6 plays important roles in the pathogenesis of a variety of diseases, in particular, chronic inflammation, autoimmune diseases, viral infection, and malignancies. 1, 2) In this study, inhibitory effects of anti-inflammatory drugs on IL-6 bioactivity were investigated. Oxyphenybutazone hydrate exhibited the highest inhibitory effect among nonsteroidal anti-inflammatory drugs (NSAIDs) and budesonide among steroidal anti-inflammatory drugs (SAIDs). were purchased from GIBCO BRL Products (Gaithersburg, MD, U.S.A.) and rhIL-6 from Wako Pure Chemical Ind., Ltd. (Osaka, Japan).
MATERIALS AND METHODS

Materials
Culture of Hybridoma MH60/BSF-2 The murine B cell hybridoma dependent on IL-6 for its growth was cultured in RPMI (10.4 mg/ml RPMI-1640, 2.48 mg/ml HEPES, 100 units/ml benzylpenicillin potassium, 100 mg/ml streptomycin sulfate, pH 7.1) containing 10% FBS and 1 unit/ml rhIL-6 at 37°C with 5% CO 2 .
17)
IL-6 Bioassay One hundred microliter of 1ϫ10 4 MH60/BSF-2 cells, 50 ml of 1.2 unit/ml rhIL-6, and 50 ml of the medium with or without sample were added to a 96-well microplate (Nunc, Roskilde, Denmark). After incubation at 37°C with 5% CO 2 for 48 h, the cell growth was measured by optical density (OD) at wavelength 570 nm using the MTT method. Effect on IL-6 bioactivity by the sample is represented as inhibition %, [1-(sample OD 570 /control OD 570 )]ϫ100, compared with the control. Data are expressed as meansϮS.E.M., and their significant differences from the controls were analyzed by Student's t-test.
IL-3 Bioassay and Cytotoxicity BAF/BO3 cell line was cultured in RPMI containing 10% FBS and 20 units/ml rmIL-3. Proliferation of BAF/BO3 by rmIL-3 was measured as an IL-3 bioassay.
18) IL-6-independent MH60 cell line was established by gradually decreasing IL-6 in RPMI containing 10% FBS for passage of MH60/BSF-2.
18) Effect on the growth rate of IL-6-independent MH60 cells in RPMI containing 10% FBS without IL-6 was viewed as the cytotoxicity of the sample.
RESULTS AND DISCUSSION
NSAIDs are well known as inhibitors of prostaglandin synthesis. However, the mechanism may not account for all pharmacological effects of NSAIDs. It was reported that indomethacin and diclofenac up-regulated the production of TNF, IFN-g and IL-2 released from Th1 cells but down-regulated the production of IL-4 and IL-6 released from Th2 Interleukin-6 (IL-6) is known as a proinflammatory cytokine involved in immune response, inflammation, and hematopoiesis. Inhibitory effects of anti-inflammatory drugs on IL-6 bioactivity using IL-6-dependent hybridoma have been evaluated. Three out of 16 nonsteroidal anti-inflammatory drugs (NSAIDs) showed IC 50 values of less than 100 m mM, which were in the order of oxyphenylbutazone hydrate (IC 50 ‫5.7؍‬ m mM)Ͼmeclofenamic acid sodium salt (31.9 m mM)Ͼsulindac (74.9 m mM). Steroidal anti-inflammatory drugs (SAIDs) exhibited significant inhibitory effects at 100 m mM on the IL-6 bioactivity, and their inhibitory potencies were in the order of budesonide (IC 50 ‫2.2؍‬ m mM)Ͼhydrocortisone 21-hemisuccinate (6.7 m mM), prednisolone (7.5 m mM), betamethasone (10.9 m mM)Ͼdex-amethasone (18.9 m mM) and triamcinolone acetonide (24.1 m mM). The results would provide an additional mechanism by which anti-inflammatory drugs display their anti-inflammatory and immunosuppressive effects at higher concentrations.
Inhibitory Effects of Anti-Inflammatory Drugs on Interleukin-6 Bioactivity
cells. 19) Five NSAIDs of diclofenac sodium salt, sulindac, meclofenamic acid sodium salt, mefenamic acid and oxyphenylbutazone hydrate exhibited significant inhibitory effects at 100 mM on IL-6 bioactivity (Table 1) . Diclofenac sodium salts and sulindac at 100 mM exhibited 42% and 79% inhibition on the cytokine bioactivity, respectively, but etodolac, indomethacin, and tolmetin sodium salt in the acetate subfamily of NSAIDs did not inhibit. Both meclofenamic acid sodium salt and mefenamic acid in the fenamate subfamily exhibited Ͼ95% and 37% inhibition at 100 mM, respectively. Oxyphenylbutazone hydrate exhibited >95% inhibition at 100 mM on IL-6 bioactivity, but phenylbutazone in the pyrazoline subfamily did not inhibit. None of NSAIDs in carboxylate, propionate and oxicam subfamilies tested in this study showed significant inhibitory effects on IL-6 bioactivity. Oxyphenylbutazone hydrate inhibited the IL-6 bioactivity in a dose-dependent manner, and showed an IC 50 value at the concentration of 7.5 mM (Fig. 1) . Based on the IC 50 values, inhibitory potency on IL-6 bioactivity was in the order of oxyphenylbutazone hydrateϾmeclofenamic acid sodium saltϾ sulindacϾdiclofenac sodium salt and mefenamic acid (Table  1) .
SAIDs are corticosteroids exerting profound effects on the inflammatory and immune responses. 20) Corticosteroid responses are initiated by binding to a specific receptor, and mediated by the cascade of cellular events involving synthesis of new proteins. It was reported that SAIDs inhibited the production of TNF, IL-1, IL-2, IL-6, IFN-g chemokine, and GM-CSF, but increased the number of receptors of IL-1 and IL-6. 20) All SAIDs exhibited significant inhibitory effects at 100 mM on IL-6 bioactivity (Table 1) . Based on the IC 50 values, inhibitory potency on IL-6 bioactivity was in the order of budesonideϾhydrocortisone 21-hemisuccinate, prednisolone, betamethasoneϾdexamethasone, triamcinolone acetonideϾ beclomethasone dipropionate. Budesonide inhibited the IL-6 bioactivity in a dose-dependent manner, and showed an IC 50 value at the concentration of 2.2 mM (Fig. 1) .
Among anti-inflammatory drugs showing >50% inhibition on IL-6 bioactivity at 100 mM, all except sulindac and budesonide inhibited the IL-3 bioactivity with potency in the order of prednisolone, hydrocortisone 21-hemisuccinate, dexamethasoneϾoxyphenylbutazone hydrate, triamcinolone ace- IL-6 bioactivity was measured by proliferation of hybridoma MH60/BSF-2 in the presence of rhIL-6. Data are represented as inhibition %, meanϮS.E. of three independent tests, and their significant differences from the control are * pϽ0.001. tonideϾmeclofenamic acid sodium salt and betamethasone ( Table 2) . None of the compounds except oxyphenylbutazone hydrate and meclofenamic acid sodium salt showed cytotoxic effects on IL-6-independent MH60 cells ( Table 2) . Several types of potential pharmaceutical agents which inhibit IL-6 synthesis or signaling have been reported including tenidap, suramin, suplatast tosylates, herbal extract of Stephania tetrandra, and marine extract of Erylus placenta. 21) Tenidap is a NSAID-like agent with an inhibitory effect on IL-6 production and exhibited inhibitory effects on acute-phase response and rheumatoid arthritis, for which IL-6 is a major mediator. 22) In this study, inhibitory effects of anti-inflammatory drugs on IL-6 bioactivity were demonstrated. Oxyphenylbutazone hydrate among NSAIDs exhibited the highest inhibitory effect with an IC 50 value of 7.5 mM, and budesonide among SAIDs showed an IC 50 value of 2.2 mM. These results would provide an additional mechanism by which the drugs exert their anti-inflammatory and immunosuppressive effects.
